As private equity increasingly invests in ASCs and physician groups, some leaders are concerned about its effect on patient outcomes and costs.
Here’s what seven ASC and physician leaders have to say about private equity in the last six months.
Jayesh Dayal, MD. Anesthesiologist at White Flint Surgery (Rockville, Md.): As a standalone ASC, we seem to have no negotiating power with any of the insurers and seem to be at the bottom of the procedure reimbursement rungs. The larger health systems, with access to hospital outpatient department rates and private-equity owned ASCs, with their nationwide heft, seem to be able to negotiate enviable rates for the same procedures.